Related Experiment Video
Updated: May 13, 2026

In Silico Clinical Trials for Cardiovascular Disease
Published on: May 27, 2022
Centers for cardiovascular outcomes research: defining a collaborative vision
Nakela L Cook1, Denise E Bonds, Catarina I Kiefe
1National Heart, Lung, and Blood Institute, 31 Center Drive, Bethesda, MD 20814, USA. nakela.cook@nih.gov
Background:
Recognizing the value of outcomes research to understand and bridge translational gaps, to establish evidence in clinical practice and delivery of medicine, and to generate new hypotheses on ongoing questions of treatment and care, the National Heart, Lung, and Blood Institute of the National Institutes of Health established the Centers for Cardiovascular Outcomes Research program in 2010.
Methods And Results:
The National Heart, Lung, and Blood Institute funded 3 centers and a research coordinating unit. Each center has an independent project focus, including (1) characterizing care transition and predicting clinical events and quality of life for patients discharged after an acute coronary syndrome; (2) identifying center and regional factors associated with better patient outcomes across several cardiovascular conditions and procedures; and (3) examining the impact of healthcare reform in Massachusetts on overall and disparate care and outcomes for several cardiovascular conditions and venous thromboembolism. Cross-program collaborations seek to advance the field methodologically and to develop early-stage investigators committed to careers in outcomes research.
Conclusions:
The Centers for Cardiovascular Outcomes Research program represents a significant investment in cardiovascular outcomes research by the National Heart, Lung, and Blood Institute. The vision of this program is to leverage scientific rigor and cross-program collaboration to advance the science of healthcare delivery and outcomes beyond what any individual unit could achieve alone.
Related Concept Videos
Coronary Artery Disease V: Interprofessional Care
Cardiomyopathy V: Interprofessional Care
Coronary Artery Disease IV: Preventive Measures
Clinical Trials: Overview
Acute Coronary Syndrome IV: Interprofessional Care
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...